Veteran Pharma Insider Buys: Biotech Stock Momentum Explored
A seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
This piece breaks down the core influences on market indices, from macro indicators to liquidity, helping you anticipate possible moves.
27,546 articlesA seasoned pharma investor places a sizable bet on Nuvation Bio as a promising drug moves forward. Learn how insider ...
A softer-than-expected 2027 COLA can catch households off guard. This guide shows how to adjust your budget now with ...
Community bankers push for a renewed review of Kraken Financial's Fed account, arguing a tightening assessment could ...
A growing number of U.S. retirees are considering Oman and other Gulf states as viable paths to retire abroad, driven...
A 68-year-old federal retiree with $1.2 million in his Thrift Savings Plan learns that choosing a survivor option per...
A rising Medicare surcharge tied to two-year look-back income means some inheritors face unexpectedly higher bills. T...
Meet Ornith, the open-source coding model built for agents rather than humans. This article breaks down how it works,...
A rising governance proposal centers on a 5% government stake in OpenAI, aiming to align AI safety with policy goals ...
Dividend-focused investors face a unique puzzle with Boeing: potential for future income vs. exposure to cyclic risk....
A veteran Bernie strategist warns Democrats are repeating past mistakes with Democratic Socialists. Mamdani’s decisiv...
Hedge fund titan Ken Griffin challenges the AI hype, insisting the revolution is misunderstood and urging investors t...
When celebrity headlines touch legal trouble abroad, ordinary people can still learn how to protect finances. This ar...